Prodia Diagnostic Line Tbk vs Jaya Swarasa Agung Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp236 (market cap 428.75B, 13.83M 24h volume), while Jaya Swarasa Agung Tbk. trades at Rp50 (market cap 54.95B). The key difference: Prodia Diagnostic Line Tbk is far larger — about 7.8× Jaya Swarasa Agung Tbk.'s market cap. Which is the better fit depends on your goals.
| PRDL | TAYS | |
|---|---|---|
Market Cap | 428.75B | 54.95B |
Volume | 13.83M | — |
Lot | 138.27K | — |
Turnover | 3.27B | — |
Average Price | 236.62 | — |
Value | 3.27B | — |
Indicative Equilibrium Price | 236 | — |
Indicative Equilibrium Volume | 1.74K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Jaya Swarasa Agung Tbk (the Company) was established based on Notarial Deed No. 4 dated May 1, 1998 of Trinawati Mulia, S.H., in Jakarta and has received approval as a legal entity from the Minister of Justice and Human Rights of the Republic from Indonesia dated July 19, 1999 through its Decision Letter No.C-13163.01.01.TH.99. The Company started its commercial operation in 1998.
Read more on TAYS →